Top Markets
Coin of the day
Regnum Corp. Regnum Corp.

Regnum Corp.

RGMP
주식 순위 #42305
Regnum Corp. is dedicated to advancing and marketing therapeutic agents... Regnum Corp. is dedicated to advancing and marketing therapeutic agents designed to combat both rare and infectious diseases. Its flagship product is Leronlimab (PRO 140), a monoclonal antibody functioning as a C-C chemokine receptor type 5 (CCR5) antagonist. This drug is specifically formulated to inhibit the human immunodeficiency virus (HIV) from gaining entry into human cells. Headquartered in New York, New York, Regnum Corp. operates as a subsidiary of Phoenixus AG.
주가
$0.0001
마지막 동기화: 2026-08-11
시가총액
$2.30K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Regnum Corp. (RGMP)

카테고리

Regnum Corp. (RGMP)의 주가 이력
최고 종가: $0.00 (2026-08-01 기준)

최저 종가: $0.15 (2019-05-01 기준)
Regnum Corp.의 주가 이력 (2019 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 0.00%
2025 0.00%
2024 -98.31%
2023 -96.26%
2022 94.68%
2021 -67.77%
2020 114.71%
2019 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.08K -6.44%
KR